SCHEMBL31268151

SCHEMBL31268151

O=C(O)C1(O)CC(Cl)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25475447 0.77
SCHEMBL28264910 0.77
SCHEMBL6433841 0.76 CYP1A2 (0.32)
SCHEMBL31268203 0.74
SCHEMBL16079341 0.74 APLNR (0.35)
SCHEMBL15233490 0.74
SCHEMBL13074445 0.74
SCHEMBL571952 0.74
SCHEMBL6686381 0.73 CYP2C19 (0.35)
Quinic Acid SCHEMBL39555 0.72 HSD17B10 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119421877-A Substituted heterocyclic compounds as HSET inhibitors 默克专利股份公司 2025-02-11 CN disclosed
CN-118892553-A Esatitecan analogue, ligand-drug conjugate thereof and application thereof 浙江大学 2024-11-05 CN disclosed